Latest News and Press Releases

Lifecore segment revenues increased 27.9% in fiscal third quarter, as compared to prior year period Reiterates fiscal 2022 full year guidance SANTA MARIA, Calif., April 05, 2022 (GLOBE NEWSWIRE)...

SANTA MARIA, Calif., March 22, 2022 (GLOBE NEWSWIRE) -- Landec Corporation (Nasdaq: LNDC) (“Landec” or the “Company”), a diversified health and wellness company focused on its growing Lifecore...

SANTA MARIA, Calif., Jan. 07, 2022 (GLOBE NEWSWIRE) -- Landec Corporation (Nasdaq: LNDC) (“Landec” or the “Company”), a diversified health and wellness company focused on its growing Lifecore...

Reiterates Fiscal 2022 Guidance for Lifecore Provides Pro Forma Curation Foods Segment Results and Updates Guidance for Continuing Segment Operations SANTA MARIA, Calif., Jan. 05, 2022 (GLOBE...

Strategic sale results in a CDMO-focused company aligned with attractive growth categories and end marketsNet proceeds from the sale will be allocated towards debt pay down, resulting in significant...

Quarterly net loss of $9.5 million, EBITDA of $1.1 million, and Adjusted EBITDA of $4.4 millionReiterates Fiscal Year 2022 Guidance SANTA MARIA, Calif., Sept. 29, 2021 (GLOBE NEWSWIRE) -- Landec...

SANTA MARIA, Calif., Sept. 15, 2021 (GLOBE NEWSWIRE) -- Landec Corporation (Nasdaq: LNDC), a diversified health and wellness company with two operating businesses, Lifecore Biomedical, Inc. and...

Lifecore Biomedical Generates Full Year Revenue Growth of 14.3%, Net Income Growth of 23.1%, and Adjusted EBITDA Growth of 22.0%Curation Foods Achieves Fiscal Fourth Quarter Gross Margin of 11.9% on...

SANTA MARIA, Calif., July 14, 2021 (GLOBE NEWSWIRE) -- Landec Corporation (Nasdaq: LNDC), a diversified health and wellness company with two operating businesses, Lifecore Biomedical, Inc. and...

Early sale to affiliates of founding and controlling investors for $45.1 million Net proceeds to be used to repay a portion of outstanding term debt and de-lever balance sheet SANTA MARIA,...